Nutriband declares a 25% preferred stock dividend, aiming for FDA approval of AVERSA Fentanyl product.

From GlobeNewswire: 2025-07-02 08:05:00

Nutriband Inc. declared a 25% preferred stock dividend, with shareholders receiving one preferred share for every four common shares held. The pay date is August 5th, with conversion to common stock possible after FDA approval of the AVERSA Fentanyl product. The goal is to create value for shareholders as commercialization nears, highlighting the manufacturing process scale-up with Kindeva. AVERSA™ technology aims to prevent abuse of transdermal patches like fentanyl. Nutriband is focused on FDA approval and development pathway finalization. Contact Nutriband Inc. at 407-377-6695 or [email protected] for more information.



Read more at GlobeNewswire: Nutriband Announces 25% Preferred Stock Dividend as it